Literature DB >> 1097595

Genetical studies of serum resistance in Escherichia coli.

P W Taylor.   

Abstract

One induced and one spontaneous serum-resistant mutant were derived from smooth serum-sensitive Escherichia coli strains. There was little difference in the yield or the O-side-chain-sugar to core-sugar ratio of lipopolysaccharides from the mutants compared with the parental strains. The mutations to serum resistance were not accompanied by increases in either the amount or haemagglutination-inhibiting activity of acidic polysaccharides extracted from the strains. Two colonially rough forms, designated 17fa and 17gb, were isolated from an aged culture of serum-resistant mutant 17. Escherichia coli 17fa appeared to be a som mutant and was rapidly killed by serum. Escherichia coli 17gb retained serological O-specificity, and 17gb lipopolysaccharide contained a full complement of O-side-chains; the strain was killed by serum but only after a delay of 1 h. Escherichia coli K-negative O8 donor Hfr59, which was serum-resistant, was crossed with rough serum-sensitive E. coli strain F470 and his+ recombinants were selected. The majority of his-+ recombinants inherited a full complement of lipopolysaccharide O-side-chains but were killed by serum after a delay of 1 to 2 h. These results suggest that lipopolysaccharide O-side-chains are responsible for a delay in the killing by normal human serum of smooth E. coli strains but that other factors determine full serum resistance. No evidence was found of a role for K-antigens in serum resistance.

Entities:  

Mesh:

Substances:

Year:  1975        PMID: 1097595     DOI: 10.1099/00221287-89-1-57

Source DB:  PubMed          Journal:  J Gen Microbiol        ISSN: 0022-1287


  18 in total

Review 1.  Escherichia coli in extra-intestinal infections.

Authors:  I Orskov; F Orskov
Journal:  J Hyg (Lond)       Date:  1985-12

2.  Resistance of Escherichia coli to osmotically introduced complement component C9.

Authors:  J R Dankert
Journal:  Infect Immun       Date:  1991-01       Impact factor: 3.441

Review 3.  Bactericidal and bacteriolytic activity of serum against gram-negative bacteria.

Authors:  P W Taylor
Journal:  Microbiol Rev       Date:  1983-03

4.  Role of lipopolysaccharide and complement in susceptibility of Klebsiella pneumoniae to nonimmune serum.

Authors:  B Ciurana; J M Tomás
Journal:  Infect Immun       Date:  1987-11       Impact factor: 3.441

5.  Role of capsule in the pathogenesis of fowl cholera caused by Pasteurella multocida serogroup A.

Authors:  J Y Chung; I Wilkie; J D Boyce; K M Townsend; A J Frost; M Ghoddusi; B Adler
Journal:  Infect Immun       Date:  2001-04       Impact factor: 3.441

6.  Plasmid-mediated resistance to the bactericidal effects of normal rabbit serum.

Authors:  A M Reynard; M E Beck
Journal:  Infect Immun       Date:  1976-09       Impact factor: 3.441

7.  TnphoA-mediated disruption of K54 capsular polysaccharide genes in Escherichia coli confers serum sensitivity.

Authors:  T A Russo; M C Moffitt; C H Hammer; M M Frank
Journal:  Infect Immun       Date:  1993-08       Impact factor: 3.441

8.  Activation of complement system by porins extracted from Salmonella typhimurium.

Authors:  F Galdiero; M A Tufano; L Sommese; A Folgore; F Tedesco
Journal:  Infect Immun       Date:  1984-11       Impact factor: 3.441

9.  Plasmid carriage and the serum sensitivity of enterobacteria.

Authors:  P W Taylor; C Hughes
Journal:  Infect Immun       Date:  1978-10       Impact factor: 3.441

10.  Selective pressures and lipopolysaccharide subunits as determinants of resistance of clinical isolates of gram-negative bacilli to human serum.

Authors:  R Porat; M A Johns; W R McCabe
Journal:  Infect Immun       Date:  1987-02       Impact factor: 3.441

View more

北京卡尤迪生物科技股份有限公司 © 2022-2023.